Background
==========

Increasing interest has focused on the relative functionality of high-density lipoprotein (HDL), highlighted by observations that cardiovascular events can occur even in the presence of high levels of HDL cholesterol. Myeloperoxidase (MPO), a heme protein abundant in leucocytes, colocalizes with HDL in the human artery wall and has emerged as a potential participant in multiple phases of the atherosclerotic process. Recently, the MPO/H~2~O~2~/SCN^-^system has been demonstrated as a dominant pathway to promote protein carbamylation within atherosclerotic plaques. Therefore, we determined whether HDL is carbamylated in the human artery wall.

Methods and results
===================

Immunohistochemical studies confirmed colocalization of carbamylated epitopes with apoA-I and macrophages in human atherosclerotic lesions. We performed shotgun proteomic analysis of in vitro carbamylated HDL to identify specific carbamylation sites of apoA-I. We could identify apoA-I-associated lysine residues in the α-helical lipid binding domains that are specifically carbamylated, indicating that carbamylation of apoA-I affects the functional integrity of HDL. In line with this observation, we observed that carbamylation of HDL (i) leads to \"non-productive\" binding to the HDL receptor (SR-BI), (ii) decreased SR-BI-mediated cholesterol efflux, and (iii) reduced HDL mediated anti-inflammatory activity.

Conclusion
==========

Taken together, our data provide strong evidence that carbamylation renders HDL dysfunctional and proinflammatory.
